Cargando…
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin Lymphoma
The treatment of young patients with Hodgkin lymphoma (HL) is often successful but a significant proportion of patients suffers from late toxicity. In the current era there are new opportunities for less toxic and more targeted treatment options. In this respect, the anti-apoptotic pathway is an att...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699187/ https://www.ncbi.nlm.nih.gov/pubmed/36430230 http://dx.doi.org/10.3390/ijms232213751 |